sunny.png
Tuesday July 27th, 2021 5:23PM

NIH: Halted vaccine study shows 'no compromises' on safety

By The Associated Press
Related Articles
  Contact Editor

WASHINGTON (AP) — The suspension of a huge COVID-19 vaccine study over an illness in a single participant shows there will be “no compromises” on safety in the race to develop the shot, the chief of the National Institutes of Health told Congress on Wednesday.

AstraZeneca has put on hold studies of its vaccine candidate in the U.S. and other countries while it investigates whether a British volunteer's illness is a side effect or a coincidence.

“This ought to be reassuring,” NIH Director Dr. Francis Collins said before a Senate committee. “When we say we are going to focus first on safety and make no compromises, here is Exhibit A of how that is happening in practice.”

Scientists have been scrambling to develop a vaccine against the coronavirus since the outbreak began, and the U.S. has launched the world's largest studies — final-stage testing of three leading candidates, with three more trials set to come soon that will each recruit 30,000 test subjects.

Public health experts are worried that President Donald Trump will pressure the Food and Drug Administration to approve a vaccine before it is proven to be safe and effective, a concern senator after senator echoed on Wednesday.

“When it comes to a COVID-19 vaccine, we can’t allow President Trump to repeat his alarming pattern of putting politics ahead of science and public health," said Sen. Patty Murray of Washington, the committee's ranking Democrat.

The U.S. has invested billions of dollars in efforts to quickly develop multiple vaccines against COVID-19. But public fears that a vaccine is unsafe or ineffective could be disastrous, derailing the effort to vaccinate millions of Americans.

Collins said the public needs to understand the process behind telling when any vaccine candidate is ready for widespread use — one that by design is keeping both manufacturers and politicians in the dark until the evidence gels.

About 150 COVID-19 infections in a study of 30,000 people should be enough to tell if that candidate really is working — and an independent group of experts, not the FDA, gets to do the counting.

WHO MONITORS THE STUDIES?

Every vaccine trial is overseen by a “data and safety monitoring board,” or DSMB. These boards include scientists and statisticians who are experts in their fields but have no ties to either the government or the vaccine makers.

The top priority: watching for safety concerns, like the one that sparked a DSMB in Britain to pause AstraZeneca's vaccinations and alert its U.S. counterpart.

But this is the group that also will decide when each vaccine is ready to be evaluated by regulators.

In each 30,000-person study, about half the participants are given the real vaccine and half get dummy shots, and neither they nor their doctors know which is which. Only the DSMB has the power to unlock the code of who got which shot and peek at how the volunteers are faring before a study is finished.

The FDA can't even begin to consider approving a vaccine until the DSMB says the data is good enough for that debate, Collins stressed. Once that happens, the FDA has pledged to bring each candidate before a public vaccine advisory committee.

DOING THE MATH

The FDA already has told manufacturers it won't consider any vaccine that's less than 50% effective.

Say one vaccine trial records that 150 volunteers have gotten sick. The DSMB finds that 100 had received dummy shots and 50 had received the real vaccine. The expert group might decide that’s a promising enough vaccine to stop the study early so that the FDA can debate its merits, even before getting final outcomes from all 30,000 volunteers, said Dr. Larry Corey of the Fred Hutchinson Cancer Research Institute, who is overseeing the U.S. government's vaccine studies.

On the other hand, if equal numbers from the vaccine and placebo groups got infected, the DSMB might declare a vaccine futile, he told The Associated Press. These panels also can calculate infections even before that 150 threshold is met, at set time points in each study.

“If your vaccine is at least 50% effective, you're going to know it because you're going to see a big skewing" of infections, NIH's Collins told the Senate's health, education, labor and pensions committee. “You count those events and you know whether it worked or not.”

ANSWERS UNLIKELY BEFORE THE U.S. ELECTION

Getting the right math before November, as Trump has promised, is “incredibly unlikely,” Corey said.

Collins expressed “cautious optimism” that one of the vaccines being tested will pan out by the end of the year but warned: “Certainly to try to predict whether it happens on a particular week before or after a particular date in early November is well beyond anything that any scientist right now could tell you.”

And even if a study has a spate of infections large enough to prove the effectiveness question, the DSMB also must be comfortable that there's enough evidence of safety before opening the books to the FDA. Generally, the FDA is requiring safety data from at least 3,000 people, Surgeon General Jerome Adams told the Senate panel.

This process isn't new — Phase 3 studies of vaccines and therapies are always done this way, though rarely in so bright a spotlight.

SUSPENDING A STUDY NOT THAT RARE

It’s not uncommon for pauses in research to investigate whether an unexpected health complaint is really related to a vaccine or not, Collins told senators worried about what the AstraZeneca suspension means for the nation's year-end goal.

“The reason we’re investing not in one but six different vaccines is because of the expectation that they won’t all work,” Collins said.

AstraZeneca gave no details on the illness, but Collins said it involved a “spinal cord problem.” Earlier-stage studies hadn't revealed any serious side effects, but that's a key reason for doing ever-larger phases of research — to widen the search for any reactions.

Final testing of two other vaccines is continuing, one created by the NIH and manufactured by Moderna Inc., the other made by Pfizer and Germany's BioNTech. Those two vaccines work differently than AstraZeneca's, and the studies already have recruited about two-thirds of the needed volunteers.

Several vaccine candidates made by Chinese companies are in late stages of testing in various countries, but with smaller numbers of volunteers. Most health authorities are skeptical about a claim of vaccine success by Russia, which has test results from just a few dozen people.

___

The Associated Press Health and Science Department receives support from the Howard Hughes Medical Institute’s Department of Science Education. The AP is solely responsible for all content.

  • Associated Categories: U.S. News, Associated Press (AP), AP National News, AP Online National News, Top U.S. News short headlines, Top General short headlines, AP Online Headlines - Washington, AP Online Congress News, AP Health, AP Business, AP Business - Corporate News, AP Business - Industries, AP Business - Health Care
© Copyright 2021 AccessWDUN.com
All rights reserved. This material may not be published, broadcast, rewritten, or redistributed without permission.
New project to probe Hurricane Maria deaths in Puerto Rico
U.S. researchers who estimated that nearly 3,000 people died in Puerto Rico in the aftermath of Hurricane Maria are now investigating deaths that might have been missed and could be linked to infrastructure damaged by the Category 4 storm
1:43PM ( 19 minutes ago )
Former WWE wrestlers' lawsuit over brain damage is dismissed
A federal appeals court has dismissed a lawsuit filed by 50 former pro wrestlers who claimed World Wrestling Entertainment failed to protect them from repeated head injuries that led to long-term brain damage
12:59PM ( 1 hour ago )
Explosive wildfires across California stoked by fierce winds
Wildfires are raging unchecked across parts of the western United States as winds sweep the region
12:53PM ( 1 hour ago )
U.S. News
Trump and Biden run vastly different pandemic campaigns
President Donald Trump and Democratic challenger Joe Biden are taking diametrically opposite approaches to campaigning during a pandemic
1:48PM ( 14 minutes ago )
UN protection back for threatened Nobel-winning Congo doctor
For weeks, a Nobel Peace Prize-winning Congolese doctor has faced death threats, leading alarmed supporters to urge the United Nations to reinstate the peacekeepers who were withdrawn from his hospital months ago
1:46PM ( 17 minutes ago )
Biden visits Michigan amid effort to rebuild 'blue wall'
Joe Biden is hoping to win back Michigan, Pennsylvania and Wisconsin this fall
1:42PM ( 20 minutes ago )
Associated Press (AP)
Luxury goods giant LVMH cancels $14.5B deal for Tiffany
Luxury goods giant LVMH is ending its months-long pursuit of jewelry retailer Tiffany & Co. The Paris-based conglomerate said that the French government requested a delay, saying it needs more time to assess the impact of proposed U.S. tariffs
12:55PM ( 1 hour ago )
Fire sweeps refugee camp on Greek island amid virus lockdown
Fire swept through a notoriously overcrowded refugee camp on the Greek island of Lesbos, causing no injuries but leaving thousands in need of emergency shelter
12:39PM ( 1 hour ago )
The Latest: Berlusconi fighting virus, talks to supporters
Ex-Premier Silvio Berlusconi, hospitalized with COVID-19 and pneumonia, has told his supporters he’s fighting to recover from this “hellish illness.”
12:17PM ( 1 hour ago )
AP National News
UK government tries to sharpen virus message in England
The British government has sought to tighten its message in England against the coronavirus, banning gatherings above six people and launching a new public information campaign
6:32AM ( 7 hours ago )
Disney criticized for filming 'Mulan' in China's Xinjiang
Disney is under fire for filming part of its live-action reboot “Mulan” in Xinjiang, the region in China where the government has been accused of human rights abuses against Uighurs and other predominantly Muslim minorities
6:10AM ( 7 hours ago )
English warned limits on gatherings may last til Christmas
British Health Secretary Matt Hancock says new limits on social gatherings in England to six people are set to stay in place for the “foreseeable future,” potentially until or even through Christmas
5:50AM ( 8 hours ago )
AP Online National News
7 killed at large-scale California marijuana operation
Authorities haven't made any arrests and haven't released a motive for a shooting at an illegal marijuana growing operation that left seven people dead
12:09AM ( 13 hours ago )
Firefighters overtaken by flames in California mountains
More than a dozen firefighters were overrun by flames while trying to protect a fire station in rugged mountains near the central California coast
11:53PM ( 14 hours ago )
Police vow to work with probe of shooting of autistic boy
A police department vowed Tuesday to cooperate with multiple investigations of the shooting of a 13-year-old autistic boy by officers in the Salt Lake City area
11:43PM ( 14 hours ago )
Top U.S. News short headlines
1,000s flee fire at migrant camp on virus lockdown in Greece
Authorities on the Greek island of Lesbos say thousands of migrants have fled a camp under COVID-19 lockdown after multiple fires gutted much of the site
11:57PM ( 14 hours ago )
North Korea's Kim urges quick recovery from typhoon damage
North Korean media say leader Kim Jong Un called for urgent efforts to rebuild thousands of homes and other structures destroyed by a typhoon that slammed the country’s east last week
11:54PM ( 14 hours ago )
Tech chills spill into Asia, as shares sink across region
Shares have fallen in Asia after a sell-off of big technology stocks on Wall Street
11:44PM ( 14 hours ago )
Top General short headlines
The Latest: NIH director: 'No compromises' on safe vaccine
The National Institutes of Health director is telling Congress that AstraZeneca’s suspension of its coronavirus vaccine study shows there will be “no compromises” on safety in developing the shots
1:08PM ( 54 minutes ago )
Top Homeland Security official defends response to protests
The head of the U.S. Department of Homeland Security is defending his response to protests in Portland, Oregon, amid criticism that the agency overstepped its authority with a heavy-handed deployment that reflected the law-and-order election campaign of President Donald Trump
12:44PM ( 1 hour ago )
US withdrawing thousands of troops from Iraq and Afghanistan
The top U.S. general for the Middle East says the Trump administration will pull thousands of troops out of Iraq and Afghanistan by November
12:33PM ( 1 hour ago )
AP Online Headlines - Washington
Paris art fair to go ahead despite virus pandemic
The coronavirus pandemic has led to the cancellation of this year’s premiere global art fairs since March, stymieing the main commercial artery of the multibillion-dollar industry
10:53AM ( 3 hours ago )
The Latest: United Arab Emirates has 883 new virus cases
The United Arab Emirates has recorded 883 new coronavirus cases, the country’s biggest daily jump since late May
8:46AM ( 5 hours ago )
Computer glitches disrupt classes as schools return online
The millions of American youngsters returning to online classes Tuesday are facing technical glitches and other headaches that have plagued remote learning since the onset of the COVID-19 pandemic
8:54PM ( 17 hours ago )
AP Health
Head of Israel's biggest bank expects deals soon with UAE
The head of Israel’s biggest bank says he expects to strike deals soon with major lenders in the United Arab Emirates for the first time
12:36PM ( 1 hour ago )
Stocks perk up on Wall Street as tech bloodletting halts
Wall Street is steadying itself Wednesday following a three-day losing streak, the first in nearly three months
12:34PM ( 1 hour ago )
Jalen Ramsey gets 5-year, $105 million extension from Rams
Jalen Ramsey is becoming the highest-paid defensive back in NFL history after agreeing to a five-year, $105 million contract extension with the Los Angeles Rams
12:06PM ( 1 hour ago )
AP Business
New project to probe Hurricane Maria deaths in Puerto Rico
U.S. researchers who estimated that nearly 3,000 people died in Puerto Rico in the aftermath of Hurricane Maria are now investigating deaths that might have been missed and could be linked to infrastructure damaged by the Category 4 storm
1:43PM ( 19 minutes ago )
Former WWE wrestlers' lawsuit over brain damage is dismissed
A federal appeals court has dismissed a lawsuit filed by 50 former pro wrestlers who claimed World Wrestling Entertainment failed to protect them from repeated head injuries that led to long-term brain damage
12:59PM ( 1 hour ago )
Explosive wildfires across California stoked by fierce winds
Wildfires are raging unchecked across parts of the western United States as winds sweep the region
12:53PM ( 1 hour ago )
GOP targets Democratic-run California in election gamble
Republicans across California are hoping to gain ground in November elections by targeting the state's dominant Democratic leadership
9:57AM ( 4 hours ago )
Gusty winds pose continued wildfire threats in California
Wildfires are raging unchecked throughout California, and authorities say gusty winds could drive flames with new ferocity
8:03AM ( 5 hours ago )